Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Randomized Trial of Intramuscular (IM) Olanzapine Versus Intramuscular Combination of Haloperidol and Lorazepam in the Treatment of Acute Agitation in Schizophrenia

NCT00797277 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00797277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00797277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Randomized Trial of Intramuscular (IM) Olanzapine Versus Intramuscular Combination of Haloperidol and Lorazepam in the Treatment of Acute Agitation in Schizophrenia
Lead sponsor
National Taiwan University Hospital
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2006
Completion date
June 30, 2009
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

agitation, schizoaffective disorder, schizophrenia